Polymyalgia Rheumatica Does NOT Cause Elevated CPK
Polymyalgia rheumatica (PMR) is characterized by normal serum creatine kinase (CPK) levels, and an elevated CPK should prompt consideration of alternative diagnoses such as polymyositis or other myopathies 1.
Key Diagnostic Feature
Normal CPK is actually a defining characteristic that helps distinguish PMR from true muscle diseases:
- PMR presents with severe myalgia and stiffness in shoulder and pelvic girdle muscles, but the muscle enzymes remain normal 1
- This is a critical distinguishing feature from polymyositis, where CPK is typically elevated
- The pain in PMR originates from bursitis and synovitis (particularly subacromial bursae), not from muscle inflammation itself 2
Clinical Implications
If you encounter a patient with suspected PMR who has elevated CPK:
- Reconsider the diagnosis - this is atypical for PMR
- Investigate for:
- Polymyositis or dermatomyositis
- Drug-induced myopathy (especially statin-related)
- Other inflammatory myopathies
- Overlap syndromes
The Rare Exception
One case report from 1979 documented abnormal EMG findings in a PMR patient with biopsy-proven giant cell arteritis, but notably even in this unusual case, the CPK and aldolase remained normal 3. This reinforces that muscle enzyme elevation is not part of the PMR disease process.
Pathophysiology Context
The immunopathophysiology of PMR involves IL-6-mediated inflammation in bursae and synovial structures, with activation of fibroblast-like synoviocytes 2. The muscle pain is referred pain from these inflamed periarticular structures, not from muscle tissue damage - which explains why muscle enzymes remain normal.